Physician profile
Erick A Greer
NPI 1780066266
$3,062.42
in general payments reported to CMS, 2019-2025
23 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $802 · 2023: $1,726 · 2024: $167 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,003.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $791.08 | 2021-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $526.61 | 2021-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $369.50 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $222.39 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $187.13 | 2023-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $184.61 | 2022-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.78 | 2022-2023 | Jardiance |
| Pfizer INC. | $157.69 | 2022-2025 | |
| Boston Scientific Corporation | $109.11 | 2022-2025 | Watchman Flx, Bodyguardian |
| Inspire Medical Systems, INC. | $47.91 | 2024 | Inspire |
| Novo Nordisk INC | $33.65 | 2022-2024 | Ozempic |
| Kiniksa Pharmaceuticals, LTD. | $33.29 | 2023 | Arcalyst |
| Philips North America LLC | $29.40 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $28.64 | 2023 | Evkeeza |
| Daiichi Sankyo INC. | $24.98 | 2023 | Injectafer |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $23.85 | 2023 | Definity |
| Amarin Pharma, INC. | $19.39 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.11 | 2022 | |
| Esperion Therapeutics, INC. | $18.14 | 2021 | |
| Merck Sharp & Dohme LLC | $18.12 | 2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $15.36 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.78 | 2023 | |
| Irhythm Technologies, INC. | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erick Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.